Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy
TC Pham, VN Nguyen, Y Choi, S Lee, J Yoon - Chemical Reviews, 2021 - ACS Publications
This review presents a robust strategy to design photosensitizers (PSs) for various species.
Photodynamic therapy (PDT) is a photochemical-based treatment approach that involves the …
Photodynamic therapy (PDT) is a photochemical-based treatment approach that involves the …
Lipid nanoparticles─ from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement
R Tenchov, R Bird, AE Curtze, Q Zhou - ACS nano, 2021 - ACS Publications
Lipid nanoparticles (LNPs) have emerged across the pharmaceutical industry as promising
vehicles to deliver a variety of therapeutics. Currently in the spotlight as vital components of …
vehicles to deliver a variety of therapeutics. Currently in the spotlight as vital components of …
[PDF][PDF] Targeting strategies for tissue-specific drug delivery
Off-target effects of systemically administered drugs have been a major hurdle in designing
therapies with desired efficacy and acceptable toxicity. Developing targeting strategies to …
therapies with desired efficacy and acceptable toxicity. Developing targeting strategies to …
Molecularly imprinted polymers: Antibody mimics for bioimaging and therapy
Molecularly imprinted polymers (MIPs) are tailor-made chemical receptors that recognize
and bind target molecules with a high affinity and selectivity. MIPs came into the spotlight in …
and bind target molecules with a high affinity and selectivity. MIPs came into the spotlight in …
Block copolymer micelles in nanomedicine applications
Polymeric micelles are demonstrating high potential as nanomedicines capable of
controlling the distribution and function of loaded bioactive agents in the body, effectively …
controlling the distribution and function of loaded bioactive agents in the body, effectively …
CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive …
A Rodriguez-Garcia, RC Lynn, M Poussin… - Nature …, 2021 - nature.com
The immunosuppressive tumor microenvironment (TME) represents a major barrier for
effective immunotherapy. Tumor-associated macrophages (TAMs) are highly heterogeneous …
effective immunotherapy. Tumor-associated macrophages (TAMs) are highly heterogeneous …
The expanding role of prodrugs in contemporary drug design and development
J Rautio, NA Meanwell, L Di… - Nature reviews drug …, 2018 - nature.com
Prodrugs are molecules with little or no pharmacological activity that are converted to the
active parent drug in vivo by enzymatic or chemical reactions or by a combination of the two …
active parent drug in vivo by enzymatic or chemical reactions or by a combination of the two …
The concept of folic acid in health and disease
Y Shulpekova, V Nechaev, S Kardasheva, A Sedova… - Molecules, 2021 - mdpi.com
Folates have a pterine core structure and high metabolic activity due to their ability to accept
electrons and react with O-, S-, N-, C-bounds. Folates play a role as cofactors in essential …
electrons and react with O-, S-, N-, C-bounds. Folates play a role as cofactors in essential …
Liposomal nanomedicine: applications for drug delivery in cancer therapy
F Rommasi, N Esfandiari - Nanoscale Research Letters, 2021 - Springer
The increasing prevalence of cancer, a disease in which rapid and uncontrollable cell
growth causes complication and tissue dysfunction, is one of the serious and tense concerns …
growth causes complication and tissue dysfunction, is one of the serious and tense concerns …
Immunogenic camptothesome nanovesicles comprising sphingomyelin-derived camptothecin bilayers for safe and synergistic cancer immunochemotherapy
Z Wang, N Little, J Chen, KT Lambesis, KT Le… - Nature …, 2021 - nature.com
Despite the enormous therapeutic potential of immune checkpoint blockade (ICB), it benefits
only a small subset of patients. Some chemotherapeutics can switch 'immune-cold'tumours …
only a small subset of patients. Some chemotherapeutics can switch 'immune-cold'tumours …